MARKET

LABT

LABT

Lakewood-Amedex
NASDAQ
0.6680
-0.0070
-1.04%
After Hours: 0.6543 -0.0137 -2.05% 19:49 06/05 EDT
OPEN
0.6990
PREV CLOSE
0.6750
HIGH
0.7095
LOW
0.6201
VOLUME
355.48K
TURNOVER
--
52 WEEK HIGH
9.82
52 WEEK LOW
0.5900
MARKET CAP
9.57M
P/E (TTM)
-2.4860
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LABT last week (0525-0529)?
Weekly Report · 5d ago
Lakewood-Amedex Biotherapeutics building broad antimicrobial platform, CEO says
TipRanks · 05/29 18:11
Lakewood-Amedex CEO says going public boosts visibility, engagement
TipRanks · 05/29 18:10
Bisphosphocin technology offers differentiated approach, Cooper says
TipRanks · 05/29 18:09
Meet Lakewood-Amedex Biotherapeutics: Fly exclusive with CEO Kelvin Cooper
TipRanks · 05/29 18:05
Lakewood-Amedex Biotherapeutics issued two new patents
TipRanks · 05/27 14:34
Lakewood-Amedex Biotherapeutics Expands Global Intellectual Property Portfolio With Issuance Of Two Patents, One Each In Australia And New Zealand Respectively
Benzinga · 05/27 12:07
Lakewood-Amedex wins Australia, New Zealand patents for Nu-3 diabetic foot ulcer gel formulation
PUBT · 05/27 12:04
More
About LABT
Lakewood-amedex Biotherapeutics Inc is a pharmaceutical company. The Company is focused on addressing unmet needs in the treatment of serious infectious diseases, improving patient outcomes, and significantly reducing the threat posed by antibiotic-resistant bacterial strains like MRSA, NDM-1, and many others. The Company is engaged in development of its Bisphosphocin class of antimicrobial agents. The Company is exploring additional local drug delivery applications, including complicated urinary tract infections (CAUTI) and pulmonary infections. The Company has a portfolio of compounds that are being profiled for indications such as infected diabetic foot ulcer, urinary tract infections, and pulmonary infections.

Webull offers Lakewood-amedex Biotherapeutics Inc stock information, including NASDAQ: LABT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LABT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LABT stock methods without spending real money on the virtual paper trading platform.